Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsSuven lifesciences

    Suven Lifesciences

    Jump to

    • Bull's Eye: Buy PNB, Havells, BEML, KPIT Tech, Kaveri Seed; sell LIC Housing

      Jay Thakkar of Anand Rathi Securities recommends buying Havells India with a target of Rs 494 and Kaveri Seed Company with a target of Rs 707.

    • Buy Texmaco Rail, Suven Life, Zee Learn: Kapur

      In CNBC-TV18's popular show Bull's Eye, Ashish Kapur, Investshoppe shares trading strategy of the day.

    • Will need 3-4 years for new patents' materialisation: Suven

      Suven Life Sciences secured three product patents (two from Eurasia and one from Canada) corresponding to the new chemical entities for the treatment of disorders associated with Neurodegenerative diseases. The patents are valid through 2027. The company's stocks rallied 5% on the news.

    • Buy Suven Life, JB Chemicals, Zee Learn: Ashish Kapur

      In CNBC-TV18's popular show Bull's Eye, Ashish Kapur, Investshoppe shares trading strategy of the day.

    • Glenmark wins case against Napo Pharma

      UR Associates has come out with his report on pharma sector. According to research firm, Indian pharma companies received 29% of total US FDA generic drug approvals during the April-August period.

    • Buy Jyothy Labs, Sundaram Fin, Suven Life: Pankaj Jain

      In CNBC-TV18's popular show Bull's Eye, Pankaj Jain, Sunteck Wealthmax shares trading strategy of the day.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347